Enhanced delivery of galanin conjugates to the brain through bioengineering of the anti-transferrin receptor antibody OX26

From National Research Council Canada

Download
  1. Available on February 27, 2019
DOIResolve DOI: https://doi.org/10.1021/acs.molpharmaceut.7b00937
AuthorSearch for: ; Search for: ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleMolecular Pharmaceutics
ISSN1543-8384
1543-8392
Abstract
Publication date
PublisherACS
LanguageEnglish
Peer reviewedYes
NPARC number23002822
Export citationExport as RIS
Report a correctionReport a correction
Record identifier6d3ae31a-111c-48fe-a726-28ae1e39763f
Record created2018-03-02
Record modified2018-03-02
Date modified: